119th Congress · introduced in the House · Jul 20, 2026
Modernizing Opioid Treatment Access Act 2.0 of 2026
Official title from Congress.gov
Latest action (Jul 20, 2026): Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
View on Congress.govPolicy area: Health
No official summary has been published for this bill.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Introduced in House
Actions from Congress.gov, newest first.
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 23, 2026.
13 citations.
AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · lobbying firm or registrant: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Alcohol and Drug Abuse
$393,240
Spent on own lobbying
…t schools receiving Federal funds to report to certain Federal information systems any distribution of an opioid overdose reversal drug, and for other purposes H.R. 9790-Modernizing Opioid Treatment Access Act 2.0, to expand access to methadone through alternative care models using pharmacies S.921-Tylers Law, to direct the Sec…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
JOHNS HOPKINS UNIVERSITY · lobbying firm or registrant: JOHNS HOPKINS UNIVERSITY
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Health Issues
$340,000
Spent on own lobbying
…Efficiency in 340B Act, S.5244, Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the future of 340B Act, 340B; H.R. 9790, Modernizing Opiod Treatment Access Act 2.0, S.4941, Modernizing Opiod Treatment Access Act 2.0, MOTAA 2.0
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
TOBACCO-FREE KIDS ACTION FUND · lobbying firm or registrant: TOBACCO-FREE KIDS ACTION FUND
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$270,000
Spent on own lobbying
…ective Recovery (PEER) Support Act H.R. 2586 - Reentry Act H.R. 1510/ S. 1720 - Due Process Continuity of Care Act S. 5425 - Addiction Grants Modernization Act H.R. 9790/S.4941 - Modernizing Opioid Treatment Access Act 2.0 Issues: Medicaid prior authorization requirements Access to addiction treatment services Overdose preventi…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN ASSOCIATION FOR THE TREATMENT OF OPIOID DEPENDENCE · lobbying firm or registrant: VAN SCOYOC ASSOCIATES
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Alcohol and Drug Abuse
$20,000
Paid to lobbying firm
Regulation regarding opioids, regulation of fentanyl and methadone access related issues H.R.9790/S.4941, Modernizing Opioid Treatment Access Act, Entirety H.R.5629, To provide that the final rule of the Department of Health and Human Services titled "Medic…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN ASSOCIATION FOR THE TREATMENT OF OPIOID DEPENDENCE · lobbying firm or registrant: VAN SCOYOC ASSOCIATES
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$20,000
Paid to lobbying firm
H.R.9790/S.4941, Modernizing Opioid Treatment Access Act, Entirety Monitor the following: H.R.2586, Reentry Act of 2025, Entirety Substance Use Disorder, Medicaid Cover…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN SOCIETY OF ADDICTION MEDICINE · lobbying firm or registrant: AMERICAN SOCIETY OF ADDICTION MEDICINE
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Alcohol and Drug Abuse
$40,000
Spent on own lobbying
…nt, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs. Advocated for S. 4941 / H.R. 9790 - the Modernizing Opioid Treatment Access Act 2.0, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that c…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN SOCIETY OF ADDICTION MEDICINE · lobbying firm or registrant: AMERICAN SOCIETY OF ADDICTION MEDICINE
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$40,000
Spent on own lobbying
…nt, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs. Advocated for S. 4941 / H.R. 9790 - the Modernizing Opioid Treatment Access Act 2.0, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that c…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN SOCIETY OF ADDICTION MEDICINE · lobbying firm or registrant: AMERICAN SOCIETY OF ADDICTION MEDICINE
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Medical/Disease Research/Clinical Labs
$40,000
Spent on own lobbying
…nt, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs. Advocated for S. 4941 / H.R. 9790 - the Modernizing Opioid Treatment Access Act 2.0, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that c…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN SOCIETY OF ADDICTION MEDICINE · lobbying firm or registrant: AMERICAN SOCIETY OF ADDICTION MEDICINE
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Medicare/Medicaid
$40,000
Spent on own lobbying
…nt, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs. Advocated for S. 4941 / H.R. 9790 - the Modernizing Opioid Treatment Access Act 2.0, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that c…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN SOCIETY OF ADDICTION MEDICINE · lobbying firm or registrant: AMERICAN SOCIETY OF ADDICTION MEDICINE
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$40,000
Spent on own lobbying
…nt, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs. Advocated for S. 4941 / H.R. 9790 - the Modernizing Opioid Treatment Access Act 2.0, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that c…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN SOCIETY OF ADDICTION MEDICINE · lobbying firm or registrant: AMERICAN SOCIETY OF ADDICTION MEDICINE
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Insurance
$40,000
Spent on own lobbying
…nt, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs. Advocated for S. 4941 / H.R. 9790 - the Modernizing Opioid Treatment Access Act 2.0, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that c…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN PSYCHOLOGICAL ASSOCIATION SERVICES INC.(FKA AMERICAN PSYCHOLOGICAL ASSN · lobbying firm or registrant: AMERICAN PSYCHOLOGICAL ASSOCIATION SERVICES INC.(FKA AMERICAN PSYCHOLOGICAL ASSN
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 16, 2026 · issue area: Health Issues
$520,000
Spent on own lobbying
…Disease Prevention in Community Health Centers Act of 2026 H.R.9551, Mental Health Parity Enforcement and Funding Act H.R. 9693, the Patients First Act of 2026 H.R. 9790/S. 4941, Modernizing Opioid Treatment Access Act 2.0 (MOTAA 2.0) H.R. 9990/S. 5120, Increasing Mental Health Options (IMHO) Act H.R.10280, 9-8-8 Implementation…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
HUBBS-SEAWORLD RESEARCH INSTITUTE · lobbying firm or registrant: HAMMER ASSOCIATES, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 2, 2026 · issue area: Budget/Appropriations
$12,000
Paid to lobbying firm
HR 9790, HR 8845 and Senate Appropriations: restorative aquaculture, Prescott Grant Funding, competitive institute programmatic grant funding, marine aquaculture, rest…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing